The short version
7 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Potassium chloride
Potassium chloride · POTASSIUM CHLORIDE 1.5 g/1.56g · For Solution · Oral · ANI Pharmaceuticals, Inc.
NDC 70954-0197-20 · 30 POUCH in 1 CARTON / 1.56 g in 1 POUCH · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for potassium chloride (other) in the next 90 days
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Where it's made
- Novitium Pharma LLCUnited Statesanalysis · label · manufacture · pack
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill · avg $24.12 per prescription
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program · Xywav and Xyrem
Regulatory
- Application
- ANDA212816
- TE code
- AA
- Approval date
- Jul 12, 2023
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Potassium chloride (For Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | POTASSIUM CHLORIDE 1.5 g/1.58g | Aug 5, 2026 | Sep 2, 2026 |
| ANI Pharmaceuticals, Inc. | POTASSIUM CHLORIDE 1.5 g/1.56g | Jul 15, 2026 | Sep 2, 2026 |
| Granules Pharmaceuticals Inc. | POTASSIUM CHLORIDE 1.5 g/1.58g | Jul 15, 2026 | Sep 2, 2026 |
| IPG Pharmaceuticals, Inc. | POTASSIUM CHLORIDE 3 g/3.16g | Jul 15, 2026 | Sep 2, 2026 |
| Lupin Pharmaceuticals,Inc. | POTASSIUM CHLORIDE 1.5 g/1.54g | Jul 15, 2026 | Sep 2, 2026 |
| Novel Laboratories, Inc. | POTASSIUM CHLORIDE 1.5 g/1.54g | Jul 15, 2026 | Sep 2, 2026 |
| Somerset Therapeutics, LLC | POTASSIUM CHLORIDE 1.5 g/1.58g | Jul 15, 2026 | Sep 2, 2026 |
| Amneal Pharmaceuticals NY LLC | POTASSIUM CHLORIDE 1.5 g/1.58g | Jul 15, 2026 | Jul 29, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Potassium chloride — NDC 70954-0197-20," retrieved September 3, 2026, https://drugdashboards.com/drug/70954019720.
Free to cite with attribution — see how the data is put together.